Sunflower Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sunflower Pharmaceutical GroupLtd has a total shareholder equity of CN¥5.3B and total debt of CN¥16.9M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥7.1B and CN¥1.9B respectively. Sunflower Pharmaceutical GroupLtd's EBIT is CN¥1.1B making its interest coverage ratio -22.5. It has cash and short-term investments of CN¥3.8B.
Key information
0.3%
Debt to equity ratio
CN¥16.91m
Debt
Interest coverage ratio | -22.5x |
Cash | CN¥3.80b |
Equity | CN¥5.28b |
Total liabilities | CN¥1.87b |
Total assets | CN¥7.15b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002737's short term assets (CN¥5.1B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 002737's short term assets (CN¥5.1B) exceed its long term liabilities (CN¥352.8M).
Debt to Equity History and Analysis
Debt Level: 002737 has more cash than its total debt.
Reducing Debt: 002737's debt to equity ratio has reduced from 15.4% to 0.3% over the past 5 years.
Debt Coverage: 002737's debt is well covered by operating cash flow (4997%).
Interest Coverage: 002737 earns more interest than it pays, so coverage of interest payments is not a concern.